期刊文献+

肌酸激酶MM同工酶在新生儿杜氏肌营养不良症筛查中的应用 被引量:4

Application of creatine kinase isoenzyme MM in screening neonatal Duchenne muscular dystrophy
下载PDF
导出
摘要 目的评估肌酸激酶MM同工酶(CK-MM)用于新生儿杜氏肌营养不良症(DMD)筛查的可行性。方法收集男性新生儿滤纸干血片样本7035份,采用时间分辨荧光法检测CK-MM,对筛查阳性的样本进行DMD基因检测。对时间分辨荧光法检测CK-MM的性能(正确度、精密度、线性范围等)进行验证。采用受试者工作特征(ROC)曲线评价CK-MM筛查DMD的效能。结果时间分辨荧光法检测CK-MM的批内CV、批间CV和平均偏移均<10%,线性回归方程为Y=1.0458X+1.9296(r=0.9999,P<0.01)。DMD患儿CK-MM浓度明显高于正常对照组(P<0.0001),是正常对照组的67倍。7035例男性新生儿筛查阳性6例(0.085%),确诊2例,DMD基因检测结果显示均为半合变异,基因型分别为c.1990C>T(p.Gln664*)和c.7657C>T(p.Arg2553*)。ROC曲线分析结果显示,CK-MM诊断DMD的曲线下面积(AUC)为1.0,最佳临界值为762 ng/mL,敏感性为100%,特异性为99.94%。结论以滤纸干血片为样本检测CK-MM能有效筛查出DMD患儿,且检测方法简便,值得临床推广。 Objective To evaluate the feasibility of creatine kinase isoenzyme MM(CK-MM)in neonatal Duchenne muscular dystrophy(DMD)screening.Methods Totally,7035 dried blood spots of male newborns were collected.CK-MM was determined by time-resolved fluorescence method,and the positive results was determined by DMD gene determination further.The performance(accuracy,precision,linear range and so on)of CK-MM determined by time-resolved fluorescence method was verified.The efficiency of CK-MM in screening DMD was evaluated by receiver operating characteristic(ROC)curve.Results The within-run coefficient of variation(CV),the between-run CV and average bias of CK-MM determined by time-resolved fluorescence method were<10%.The linear regression equation was Y=1.0458X+1.9296(r=0.9999,P<0.01).The concentration of CK-MM in children with DMD was higher than that in healthy control group(P<0.0001),which was 67 times higher than that of healthy control group.Among the 7035 male newborns,6(0.085%)cases were positive after screening,and 2 cases were confirmed.DMD gene determination results showed that all of them were hemizygous mutation,and their genotypes were c.1990C>T(p.Gln664*)and c.7657C>T(p.Arg2553*).ROC curve analysis showed that the area under curve(AUC)of CK-MM for the diagnosis of DMD was 1.0,the optimal cut-off value was 762 ng/mL,the sensitivity was 100%,and the specificity was 99.94%.Conclusions Using dried blood spots to determine CK-MM can effectively screen the children with DMD,and this method is simple and worthy of clinical application.
作者 王燕敏 田国力 纪伟 张潇分 WANGYanmin;TIAN Guoli;JI Wei;ZHANG Xiaofen(Neonatal Screening Center,Shanghai Children's Hospital,Shanghai 200040,China)
出处 《检验医学》 CAS 2020年第11期1115-1119,共5页 Laboratory Medicine
基金 国家自然科学基金青年科学基金项目(21803009) 上海市科学技术委员会科研项目(18441905100) 上海市重中之重临床重点专科建设项目(2017ZZ02019)。
关键词 肌酸激酶MM同工酶 杜氏肌营养不良症 滤纸干血片 Creatine kinase isoenzyme MM Duchenne muscular dystrophy Dried blood spot
  • 相关文献

参考文献3

二级参考文献80

  • 1Qing Ke,Zheng-Yan Zhao,Robert Griggs,Veronica Wiley,Anne Connolly,Jennifer Kwon,Ming Qi,Daniel Sheehan,Emma Ciafaloni,R Rodney Howell,Petra Furu,Peter Sazani,Arvind Narayana,Michele Gatheridge.Newborn screening for Duchenne muscular dystrophy in China: follow-up diagnosis and subsequent treatment[J].World Journal of Pediatrics,2017,13(3):197-201. 被引量:17
  • 2张成.Duchenne型肌营养不良治疗的研究进展[J].中国现代神经疾病杂志,2007,7(2):120-125. 被引量:7
  • 3Emery AE. Population frequencies of inherited neuromuscular diseases: a world survey. Neuromuscul Disord, 1991,1:19-29.
  • 4Mendell JR, Shilling C, Leslie ND, Flanigan KM, al-Dahhak R, Gastier - Foster J, Kneile K, Dunn DM, Duval B, Aoyagi A, Hamil C, Mahmoud M, Roush K, Bird L, Rankin C, Lilly H, Street N, Chandrasekar H, Weiss RB. Evidence-based path to newborn screening for Duchenne muscular dystrophy. Ann Neurol, 2012, 71:304-313.
  • 5Dooley J, Gordon KE, Dodds L, MacSween J. Duchenne muscular dystrophy: a 30 · year population · based incidence study. Clin Pediatr (Phila), 2010, 49:177-179.
  • 6Landfeldt E, Lindgren P, Bell CF, Schmitt C, Guglieri M, Straub V, Lochmiiller H, Bushby K. The burden of Duchenne muscular dystrophy: an international, cross - sectional study. Neurology, 2014,83:529-536.
  • 7Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, Kaul A, Kinnett K,McDonald C, Pandya S, Poysky J, Shapiro F, Tomezsko J, Constantin C; DMD Care Considerations Working Group. Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. Lancet Neurol, 2010, 9:177-189.
  • 8Kim HK, Merrow AC, Shiraj S, Wong BL, Horn PS, Laor T. Analysis of fatty infiltration and inflammation of the pelvic and thigh muscles in boys with Duchenne muscular dystrophy (DMD): grading of disease involvement on MR imaging andcorrelation with clinical assessments. Pediatr Radiol, 2013, 43: 1327-1335.
  • 9Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, Kaul A, Kinnett K, McDonald C, Pandya S, Poysky J, Shapiro F, Tomezsko J, Constantin C; DMD Care Considerations Working Group. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol, 2010, 9:77-93.
  • 10Imbornoni L, Price ET, Andrews J, Meaney FJ, Ciafaloni E, Cunniff C. Diagnostic and clinical characteristics of early -manifesting females with Duchenne or Becker muscular dystrophy. Am J Med Genet A, 2014,164A:2769-2774.

共引文献57

同被引文献24

引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部